Matt Miksic
Stock Analyst at Barclays
(3.91)
# 1,867
Out of 4,988 analysts
807
Total ratings
54.9%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterated: Buy | $96 → $89 | $43.34 | +105.35% | 50 | May 28, 2026 | |
| PODD Insulet | Reiterated: Sell | $198 | $140.60 | +40.83% | 20 | May 28, 2026 | |
| DXCM DexCom | Rated: Sell | $67 → $64 | $89.35 | -28.37% | 22 | May 18, 2026 | |
| AVR Anteris Technologies Global | Reiterated: Buy | $17 → $18 | $8.16 | +120.59% | 6 | May 15, 2026 | |
| HUMA Humacyte | Rated: Buy | $1.5 | $0.5856 | +156.15% | 4 | May 13, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $255 | $269.99 | -5.55% | 93 | May 13, 2026 | |
| OBIO Orchestra BioMed Holdings | Rated: Buy | $12 → $13 | $6.08 | +113.82% | 7 | May 13, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $202 → $204 | $180.94 | +12.74% | 23 | May 11, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $123 | $74.08 | +66.04% | 49 | May 11, 2026 | |
| SENS Senseonics Holdings | Reiterated: Buy | $31 | $9.58 | +223.59% | 7 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $55 | $16.87 | +226.02% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $19 | $14.35 | +32.40% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $76 | $78.01 | -2.58% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $24 | $10.18 | +135.76% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 74.22 → CHF 64.32 | CHF 53.66 | +19.87% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $22.80 | +18.42% | 41 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $469 → $394 | $275.12 | +43.21% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $16.85 | +18.69% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $87 → $78 | $64.13 | +21.63% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $100 → $94 | $95.36 | -1.43% | 40 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $110 | $88.26 | +24.63% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $712 → $651 | $393.33 | +65.51% | 19 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $144 → $143 | $102.61 | +39.36% | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 → $120 | $92.13 | +30.25% | 68 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $21.79 | +19.32% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 | $55.29 | +86.29% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.42 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $722 → $418 | $147.61 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $13 | $0.0311 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $28 | $18.73 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $67 | $9.54 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $84.84 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 → $87 | $15.22 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $23.35 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $4.77 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $2.10 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 | $27.56 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $10.54 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $45.42 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $8.71 | n/a | 3 | Mar 14, 2013 |
Boston Scientific
May 28, 2026
Reiterated: Buy
Price Target: $96 → $89
Current: $43.34
Upside: +105.35%
Insulet
May 28, 2026
Reiterated: Sell
Price Target: $198
Current: $140.60
Upside: +40.83%
DexCom
May 18, 2026
Rated: Sell
Price Target: $67 → $64
Current: $89.35
Upside: -28.37%
Anteris Technologies Global
May 15, 2026
Reiterated: Buy
Price Target: $17 → $18
Current: $8.16
Upside: +120.59%
Humacyte
May 13, 2026
Rated: Buy
Price Target: $1.5
Current: $0.5856
Upside: +156.15%
Johnson & Johnson
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $269.99
Upside: -5.55%
Orchestra BioMed Holdings
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $6.08
Upside: +113.82%
Becton, Dickinson and Company
May 11, 2026
Rated: Buy
Price Target: $202 → $204
Current: $180.94
Upside: +12.74%
Globus Medical
May 11, 2026
Reiterated: Buy
Price Target: $123
Current: $74.08
Upside: +66.04%
Senseonics Holdings
May 11, 2026
Reiterated: Buy
Price Target: $31
Current: $9.58
Upside: +223.59%
May 8, 2026
Reiterated: Buy
Price Target: $56 → $55
Current: $16.87
Upside: +226.02%
May 7, 2026
Reiterated: Buy
Price Target: $21 → $19
Current: $14.35
Upside: +32.40%
May 7, 2026
Reiterated: Hold
Price Target: $73 → $76
Current: $78.01
Upside: -2.58%
May 6, 2026
Reiterated: Buy
Price Target: $27 → $24
Current: $10.18
Upside: +135.76%
May 6, 2026
Reiterated: Hold
Price Target: CHF 74.22 → CHF 64.32
Current: CHF 53.66
Upside: +19.87%
May 4, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $22.80
Upside: +18.42%
May 1, 2026
Reiterated: Buy
Price Target: $469 → $394
Current: $275.12
Upside: +43.21%
Apr 30, 2026
Reiterated: Hold
Price Target: $20
Current: $16.85
Upside: +18.69%
Apr 30, 2026
Reiterated: Hold
Price Target: $87 → $78
Current: $64.13
Upside: +21.63%
Apr 29, 2026
Reiterated: Sell
Price Target: $100 → $94
Current: $95.36
Upside: -1.43%
Apr 24, 2026
Reiterated: Buy
Price Target: $104 → $110
Current: $88.26
Upside: +24.63%
Apr 23, 2026
Rated: Buy
Price Target: $712 → $651
Current: $393.33
Upside: +65.51%
Apr 20, 2026
Rated: Buy
Price Target: $144 → $143
Current: $102.61
Upside: +39.36%
Apr 1, 2026
Reiterated: Buy
Price Target: $118 → $120
Current: $92.13
Upside: +30.25%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $21.79
Upside: +19.32%
Mar 24, 2026
Reiterated: Buy
Price Target: $103
Current: $55.29
Upside: +86.29%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $1.42
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $722 → $418
Current: $147.61
Upside: n/a
Mar 4, 2022
Reiterated: Buy
Price Target: $16 → $13
Current: $0.0311
Upside: n/a
Mar 2, 2022
Reiterated: Buy
Price Target: $31 → $28
Current: $18.73
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $74 → $67
Current: $9.54
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $100
Current: $84.84
Upside: n/a
Nov 3, 2021
Reiterated: Buy
Price Target: $79 → $87
Current: $15.22
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $23.35
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $4.77
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $2.10
Upside: n/a
Nov 3, 2014
Reiterated: Hold
Price Target: $37
Current: $27.56
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $10.54
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $45.42
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $8.71
Upside: n/a